CITR · Citrotech Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $344.9K | - | $288.2K | $687.6K | $969.4K | - | $107.0K | $198.7K | $433.0K | - |
| Cost of Revenue | $225.6K | - | $139.2K | $371.4K | $557.0K | - | - | $89.9K | $89.9K | - |
| Gross Profit | $119.3K | - | $149.0K | $316.2K | $412.4K | - | - | $108.7K | $343.1K | - |
| R&D | $81.5K | - | - | - | - | - | - | - | - | - |
| SG&A | $410.0K | - | $349.4K | $311.5K | $211.2K | - | $194.4K | $199.5K | $197.4K | - |
| Total Operating Expenses | $4.79M | - | $4.53M | $3.71M | $4.43M | - | $668.4K | $1.11M | $2.98M | - |
| D&A | $125.7K | - | $90.1K | $77.1K | $74.5K | - | $63.6K | $62.1K | $63.8K | - |
| Operating Income | ($4.45M) | - | ($4.24M) | ($3.02M) | ($3.46M) | - | ($561.4K) | ($907.4K) | ($2.64M) | - |
| Interest Expense | $164.8K | - | $360.2K | $552.1K | $410.8K | - | $93.9K | $0 | $885 | - |
| Income Tax | $0 | - | $0 | $0 | $0 | - | $0 | $0 | $0 | - |
| Net Income | ($6.21M) | - | ($7.93M) | ($11.90M) | ($10.90M) | - | ($655.2K) | ($907.4K) | ($3.52M) | - |
| EPS - Basic | ($1.37) | - | - | - | - | - | - | ($0.02) | ($0.04) | - |
| EPS - Diluted | ($0.33) | - | ($0.59) | ($0.19) | ($0.23) | - | ($0.09) | ($0.01) | ($0.03) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.29M | $6.27M | $6.20M | $2.33M | $3.74M | $775.1K | $309.1K | $546.6K | $371.1K | $549.8K |
| Accounts Receivable | $130.3K | $209.0K | $508.2K | $654.0K | $745.8K | $317.5K | $429.9K | $650.9K | $681.0K | $427.4K |
| Inventory | $696.1K | $620.8K | $467.3K | $409.9K | $312.5K | $324.7K | $271.1K | $192.1K | $188.8K | $230.2K |
| Accounts Payable | - | - | $570.6K | $343.3K | $48.2K | - | - | - | - | - |
| Current Assets | $5.63M | $7.42M | $7.26M | $3.78M | $5.01M | $1.62M | $1.11M | $1.44M | $1.25M | $1.22M |
| Total Assets | $12.24M | $14.18M | $12.26M | $8.69M | $9.05M | $5.48M | $4.95M | $5.35M | $5.25M | $5.30M |
| Current Liabilities | $2.85M | $2.17M | $2.97M | $5.80M | $4.96M | $2.16M | $2.11M | $2.13M | $1.46M | $1.62M |
| Long-term Debt | - | - | $0 | - | - | - | - | - | - | - |
| Total Liabilities | $3.56M | $2.92M | $3.75M | $6.50M | $4.96M | $2.16M | $2.11M | $2.14M | $1.49M | $1.67M |
| Stockholders' Equity | $8.69M | $11.26M | $8.51M | $2.19M | $4.09M | $3.32M | $2.83M | $3.22M | $3.76M | $3.64M |
| Retained Earnings | ($119.41M) | ($113.20M) | ($107.10M) | ($99.17M) | ($87.27M) | ($76.37M) | ($74.57M) | ($73.91M) | ($73.00M) | ($69.48M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($2.06M) | - | - | - | ($713.9K) | - | - | - | ($343.7K) | - |
| Investing Cash Flow | ($10.7K) | - | - | - | $0 | - | - | - | - | - |
| Financing Cash Flow | $88.4K | - | - | - | $3.71M | - | - | - | $165.0K | - |
| CapEx | $10.7K | - | - | - | $0 | - | - | - | - | - |
| Free Cash Flow | ($2.07M) | - | - | - | ($713.9K) | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 34.6% | - | 51.7% | 46.0% | 42.5% | - | - | 54.7% | 79.2% | - |
| Operating margin | -1289.3% | - | -1470.3% | -438.8% | -356.8% | - | -524.4% | -456.7% | -608.9% | - |
| EBITDA margin | -1252.9% | - | -1439.1% | -427.6% | -349.1% | - | -465.0% | -425.5% | -594.1% | - |
| Net margin | -1800.6% | - | -2751.2% | -1731.1% | -1124.8% | - | -612.1% | -456.7% | -812.8% | - |
| Free cash flow margin | -600.2% | - | - | - | -73.6% | - | - | - | - | - |
| FCF / Net income | 0.33 | - | - | - | 0.07 | - | - | - | - | - |
| R&D / Revenue | 23.6% | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 118.9% | - | 121.2% | 45.3% | 21.8% | - | 181.6% | 100.4% | 45.6% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -50.7% | - | -64.7% | -137.0% | -120.5% | - | -13.2% | -16.9% | -67.0% | - |
| Return on equity | -71.5% | - | -93.2% | -543.4% | -266.5% | - | -23.1% | -28.2% | -93.5% | - |
| Return on invested capital | - | - | -39.3% | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.97 | 3.42 | 2.44 | 0.65 | 1.01 | 0.75 | 0.53 | 0.67 | 0.86 | 0.75 |
| Quick ratio | 1.73 | 3.13 | 2.28 | 0.58 | 0.95 | 0.60 | 0.40 | 0.58 | 0.73 | 0.61 |
| Cash ratio | 1.50 | 2.89 | 2.08 | 0.40 | 0.75 | 0.36 | 0.15 | 0.26 | 0.25 | 0.34 |
| Leverage | ||||||||||
| Debt / Equity | - | - | 0.00 | - | - | - | - | - | - | - |
| Debt / Assets | - | - | 0.00 | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -27.0x | - | -11.8x | -5.5x | -8.4x | - | -6.0x | - | -2979.1x | - |
| Equity multiplier | 1.41 | 1.26 | 1.44 | 3.97 | 2.21 | 1.65 | 1.75 | 1.66 | 1.40 | 1.46 |
| Liabilities / Assets | 0.29 | 0.21 | 0.31 | 0.75 | 0.55 | 0.39 | 0.43 | 0.40 | 0.28 | 0.31 |
| Efficiency | ||||||||||
| Asset turnover | 0.03 | - | 0.02 | 0.08 | 0.11 | - | 0.02 | 0.04 | 0.08 | - |
| Inventory turnover | 0.32 | - | 0.30 | 0.91 | 1.78 | - | - | 0.47 | 0.48 | - |
| Days sales outstanding | 138d | - | 644d | 347d | 281d | - | 1466d | 1196d | 574d | - |
| Days inventory outstanding | 1126d | - | 1226d | 403d | 205d | - | - | 780d | 767d | - |
| Days payable outstanding | - | - | 1496d | 337d | 32d | - | - | - | - | - |
| Cash conversion cycle | - | - | 373d | 413d | 454d | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -64.4% | - | 169.3% | 246.1% | 123.9% | - | -38.7% | 600.6% | 678.9% | - |
| Revenue CAGR (3y) | 83.7% | - | 147.4% | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -71.1% | - | - | 190.9% | 20.2% | - | - | 363.4% | 722.1% | - |
| Operating income growth (YoY) | -28.6% | - | -654.9% | -232.6% | -31.2% | - | 93.8% | -155.3% | -646.0% | - |
| Net income growth (YoY) | 43.0% | - | -1110.1% | -1211.9% | -209.8% | - | 92.7% | -154.8% | -895.4% | - |
| EPS growth (YoY) | -43.5% | - | -555.6% | -1800.0% | -666.7% | - | - | 83.3% | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -190.0% | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 112.3% | 239.7% | 200.4% | -31.9% | 8.7% | -8.8% | -19.2% | 8.5% | 22.1% | 8.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$2.38M totalProducts Sale$1.35M · 56.7%
Product Installation Service$1.03M · 43.3%
Peer comparison
Same SIC group: Chemicals & Allied Products
Comparing CitroTech Inc. against the 5 most active filers in the same SIC group.